| Dr Harold Wayne Ray Jr, | |
|
3215 Gateway Blvd W, El Paso, TX 79903 | |
| (915) 598-7246 | |
| (915) 633-6598 |
| Full Name | Dr Harold Wayne Ray Jr |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 10 Years |
| Location | 3215 Gateway Blvd W, El Paso, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811314149 | NPI | - | NPPES |
| 398428801 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | R7861 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Epmed, Pa | 9032269881 | 18 |
News Archive
The Canadian Task Force on Preventive Health Care has published new recommendations that rule out the need to do a thyroid screening test "just because" if the patient doesn't have symptoms of thyroid abnormality, is an adult, isn't pregnant, and has no risk factors for thyroid disease. This should put to rest any doubts that thyroid screening is a part of a routine check-up.
Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.
Chemists at the University of California San Diego have designed a set of molecules that promote microscopic, anatomical changes in neurons associated with the formation and retention of memories. These drug candidates also prevent deterioration of the same neuronal structures in the presence of amyloid-beta, a protein fragment that accumulates in the brains of people with Alzheimer's disease.
NeoChord, Inc., a venture-backed, Minneapolis-based medical technology company, announced today that it has enrolled the first patient in its European clinical trial. The trial, known as TACT (transapical artificial chordae tendineae) is being conducted in Germany, Denmark, Czech Republic and Norway.
BME, Inc., the privately held U.S. Leader in Nitinol Technology Implants and Instruments known under the brands of: Speed™ (fully-disposable continuous active compression system), HammerLock® (intramedullary hammertoe correction system), OSStaple™ (Nitinol continuous active compression system) and OSSforce™ (heat-activating implant controller), has announced today its' introduction of a new, improved Speed™ Continuous Active Compression System.
› Verified 3 days ago
| Entity Name | Epmed, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437616216 PECOS PAC ID: 9032269881 Enrollment ID: O20190402000278 |
News Archive
The Canadian Task Force on Preventive Health Care has published new recommendations that rule out the need to do a thyroid screening test "just because" if the patient doesn't have symptoms of thyroid abnormality, is an adult, isn't pregnant, and has no risk factors for thyroid disease. This should put to rest any doubts that thyroid screening is a part of a routine check-up.
Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.
Chemists at the University of California San Diego have designed a set of molecules that promote microscopic, anatomical changes in neurons associated with the formation and retention of memories. These drug candidates also prevent deterioration of the same neuronal structures in the presence of amyloid-beta, a protein fragment that accumulates in the brains of people with Alzheimer's disease.
NeoChord, Inc., a venture-backed, Minneapolis-based medical technology company, announced today that it has enrolled the first patient in its European clinical trial. The trial, known as TACT (transapical artificial chordae tendineae) is being conducted in Germany, Denmark, Czech Republic and Norway.
BME, Inc., the privately held U.S. Leader in Nitinol Technology Implants and Instruments known under the brands of: Speed™ (fully-disposable continuous active compression system), HammerLock® (intramedullary hammertoe correction system), OSStaple™ (Nitinol continuous active compression system) and OSSforce™ (heat-activating implant controller), has announced today its' introduction of a new, improved Speed™ Continuous Active Compression System.
› Verified 3 days ago
| Entity Name | Gateway Surgical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1124587548 PECOS PAC ID: 4789919598 Enrollment ID: O20190717000293 |
News Archive
The Canadian Task Force on Preventive Health Care has published new recommendations that rule out the need to do a thyroid screening test "just because" if the patient doesn't have symptoms of thyroid abnormality, is an adult, isn't pregnant, and has no risk factors for thyroid disease. This should put to rest any doubts that thyroid screening is a part of a routine check-up.
Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.
Chemists at the University of California San Diego have designed a set of molecules that promote microscopic, anatomical changes in neurons associated with the formation and retention of memories. These drug candidates also prevent deterioration of the same neuronal structures in the presence of amyloid-beta, a protein fragment that accumulates in the brains of people with Alzheimer's disease.
NeoChord, Inc., a venture-backed, Minneapolis-based medical technology company, announced today that it has enrolled the first patient in its European clinical trial. The trial, known as TACT (transapical artificial chordae tendineae) is being conducted in Germany, Denmark, Czech Republic and Norway.
BME, Inc., the privately held U.S. Leader in Nitinol Technology Implants and Instruments known under the brands of: Speed™ (fully-disposable continuous active compression system), HammerLock® (intramedullary hammertoe correction system), OSStaple™ (Nitinol continuous active compression system) and OSSforce™ (heat-activating implant controller), has announced today its' introduction of a new, improved Speed™ Continuous Active Compression System.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harold Wayne Ray Jr, 3215 Gateway Blvd W, El Paso, TX 79903-4225 Ph: (915) 598-7246 | Dr Harold Wayne Ray Jr, 3215 Gateway Blvd W, El Paso, TX 79903 Ph: (915) 598-7246 |
News Archive
The Canadian Task Force on Preventive Health Care has published new recommendations that rule out the need to do a thyroid screening test "just because" if the patient doesn't have symptoms of thyroid abnormality, is an adult, isn't pregnant, and has no risk factors for thyroid disease. This should put to rest any doubts that thyroid screening is a part of a routine check-up.
Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.
Chemists at the University of California San Diego have designed a set of molecules that promote microscopic, anatomical changes in neurons associated with the formation and retention of memories. These drug candidates also prevent deterioration of the same neuronal structures in the presence of amyloid-beta, a protein fragment that accumulates in the brains of people with Alzheimer's disease.
NeoChord, Inc., a venture-backed, Minneapolis-based medical technology company, announced today that it has enrolled the first patient in its European clinical trial. The trial, known as TACT (transapical artificial chordae tendineae) is being conducted in Germany, Denmark, Czech Republic and Norway.
BME, Inc., the privately held U.S. Leader in Nitinol Technology Implants and Instruments known under the brands of: Speed™ (fully-disposable continuous active compression system), HammerLock® (intramedullary hammertoe correction system), OSStaple™ (Nitinol continuous active compression system) and OSSforce™ (heat-activating implant controller), has announced today its' introduction of a new, improved Speed™ Continuous Active Compression System.
› Verified 3 days ago
Dr. Eduardo Genaro Vazquez, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3215 Gateway Blvd W, El Paso, TX 79903 Phone: 915-598-7246 Fax: 915-633-6598 | |
Jose Luis Villarreal, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 5652 N Mesa, El Paso, TX 79912 Phone: 915-351-1155 Fax: 915-351-1230 | |
Dr. Manouchehr Refaeian, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 10412 Vista Del Sol Dr, Suite 1-b, El Paso, TX 79925 Phone: 915-593-9300 Fax: 915-593-9310 | |
Anthony Frances Valdez, M.D. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 9001 Cashew Dr, Ste. 100, El Paso, TX 79907 Phone: 915-860-2041 Fax: 915-860-2067 |